Consistent with this finding, ramatroban has been shown to abrogate blood eosinophilia induced by a CRTH2-specific agonist in rats [19] and to inhibit PGD2-stimulated human eosinophil migration in vitro [25]. The gene discussed is PTGDR2; the disease is Increased total eosinophil count.